Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
02/01/1996 | CA2560114A1 Immunomodulatory oligonucleotides |
02/01/1996 | CA2195450A1 Antisense oligonucleotides of pleiotrophin |
02/01/1996 | CA2194886A1 Novel chemical compound, its preparation and use as a drug |
02/01/1996 | CA2194877A1 Heterocycle-condensed morphinoid derivatives |
02/01/1996 | CA2192478A1 Quinoline derivatives as leukotriene antagonists |
01/31/1996 | EP0694542A1 Process for racemisation of enantiomers of alpha-lipoic acid |
01/31/1996 | EP0694307A1 Atopic disease remedy |
01/31/1996 | EP0693928A1 Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue |
01/31/1996 | EP0608353B1 LOW pH AQUEOUS COSMETIC GEL CONTAINING NON-IONIC POLYACRYLAMIDE DERIVATIVES |
01/31/1996 | EP0593615B1 Aromatic compounds, compositions containing them and their use in therapy |
01/31/1996 | CN1115982A Pharmacologically active pyridine derivatives and processes for the preparation thereof |
01/31/1996 | CN1115642A Analgesic 'Kangnaipan' |
01/31/1996 | CA2154910A1 Method for the racemisation of enantiomers of .alpha.-lipoic acid |
01/30/1996 | US5488135 Bis(phenyl)ethane derivatives |
01/30/1996 | US5488048 Aminoacetylmercapto derivatives useful as inhibitors of enkephalinase and ace |
01/30/1996 | CA2031572C Non-alcoholic delivery system for orally ingestible active ingredients |
01/30/1996 | CA1338012C Pharmaceutically active amines |
01/25/1996 | WO1996001847A1 Diagnostic methods and compositions relating to the proteoglycan proteins of cartilage breakdown |
01/25/1996 | WO1996001825A1 Heterobicyclic derivatives |
01/25/1996 | WO1996001819A1 Heterocyclic tachykinin receptor antagonists |
01/25/1996 | WO1996001817A1 Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase |
01/25/1996 | WO1996001646A1 Invariant chain compositions useful for treating autoimmune diseases |
01/25/1996 | WO1996001645A1 Use of muramyl peptide compounds |
01/25/1996 | WO1996001644A1 Inhibitors of leukocyte adhesion |
01/25/1996 | WO1996001636A1 A method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders |
01/25/1996 | WO1996001561A1 Method of regulating immune function |
01/25/1996 | CA2194872A1 Pyridopyrazine derivatives |
01/25/1996 | CA2194678A1 Use of muramyl peptide compounds |
01/25/1996 | CA2194550A1 Invariant chain compositions useful for treating autoimmune diseases |
01/25/1996 | CA2194366A1 A method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders |
01/25/1996 | CA2193508A1 Inhibitors of leukocyte adhesion |
01/25/1996 | CA2188680A1 Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase |
01/24/1996 | EP0693489A1 Heterocyclic tachykinin receptor antagonists |
01/24/1996 | EP0693475A1 1-Phenyl-3-dimethylamino-propane derivatives having pharmacological activity |
01/24/1996 | EP0693080A1 New glucocorticoids |
01/24/1996 | EP0693079A1 Derivatives of triterpenoid acids and uses thereof |
01/24/1996 | EP0693059A1 Perhydroisoindole derivatives, preparation thereof and pharmaceutical compositions containing same |
01/24/1996 | EP0693054A1 Cycloalkylhydroxyureas and their use as lipoxygenase inhibitors |
01/24/1996 | EP0451216B1 Humanized immunoglobulins and their production and use |
01/24/1996 | CN1115240A Pill for stimulating circulation of blood and causing muscles and joints to relax |
01/23/1996 | US5486623 Cysteine protease inhibitors containing heterocyclic leaving groups |
01/23/1996 | US5486534 3,4-substituted pyrazoles for the treatment of inflammation |
01/23/1996 | US5486529 Certain pyridyl ketones for treating diseases involving leukocyte elastase |
01/23/1996 | US5486525 Platelet activating factor antagonists: imidazopyridine indoles |
01/23/1996 | CA2154116A1 1-aryl-2-acetamidopentanone derivatives for use as tachykinin receptor antagonists |
01/23/1996 | CA1337990C Substituted azetidinones as anti-inflammatory antidegenerative agents |
01/18/1996 | WO1996001271A1 Platelet-endothelial cell adhesion molecule-1 compositions and methods |
01/18/1996 | WO1996001270A1 Human elastase iv |
01/18/1996 | WO1996001117A1 Drugs containing metronidazole or a synergistic mixture of metronidazole and clindamycin |
01/18/1996 | WO1996001115A1 Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis |
01/18/1996 | DE4424714A1 Neue chemische Verbindung, ihre Herstellung und ihre Verwendung als Arnzneistoff New chemical compound, their preparation and their use as Arnzneistoff |
01/18/1996 | DE4424713A1 Substituierte Benzamidine, ihre Herstellung und Verwendung als Arnzneistoffe Substituted benzamidines, their preparation and use as Arnzneistoffe |
01/18/1996 | CA2194396A1 Platelet-endothelial cell adhesion molecule-1 compositions and methods |
01/18/1996 | CA2194391A1 Human elastase iv |
01/17/1996 | EP0691971A1 7-azabicyclo- 2.2.1]-heptane and -heptene derivatives as analgesics and anti-inflammatory agents |
01/17/1996 | EP0691966A1 Quinolines as type iv phosphodiesterase inhibitors |
01/17/1996 | EP0691813A1 Derivatives of triterpenoid acids as inhibitors of cell-adhesion molecules elam-1 (e-selectin) and lecam-1 (l-selectin) |
01/17/1996 | EP0602028B1 Aromatic sulfonamide derivatives, their use as enzyme inhibitors and pharmaceutical compositions containing them |
01/17/1996 | EP0537313B1 Arylalkyl esters of 4,5-dihydroxy-9,10-dihydro-9,10-dioxo-2-anthracenecarboxylic acid having therapeutical activity |
01/17/1996 | EP0436526B1 Use of antibodies to angiogenin: immunotherapeutic agents |
01/17/1996 | CN1114961A Peptide inhibitors of cell adhesion |
01/17/1996 | CN1114957A New (thia)cycloalkyl|b¨indole compounds, process for the preparation thereof, and pharmaceutical compositions containing them |
01/17/1996 | CN1030718C Superoxide dismutase |
01/17/1996 | CN1030703C Neurokinin A antagonists |
01/17/1996 | CN1030702C 芪衍生物 Stilbene derivatives |
01/16/1996 | US5484942 Chemical intermediates for compounds that are antagonist for substance p such as analgesics, antiinflammatory agents, cns agents, antispasmodics or immunological effects |
01/16/1996 | US5484935 Pharmaceutical compounds |
01/16/1996 | US5484891 Pure polypeptide able to hybridize under low stringency conditions; glycoproteins |
01/16/1996 | US5484833 Derivatives of non-steroidal anti-inflammatory, analgesic and/or antipyretic substances, their use and pharmaceutical formulations containing them |
01/16/1996 | US5484810 Tissue protective tocopherol analogs |
01/16/1996 | US5484808 Methods of inhibiting cell-cell adhesion |
01/16/1996 | US5484805 Heterocyclene derivatives |
01/16/1996 | US5484804 Perhydroisoindole derivatives as antagonists of substance P |
01/16/1996 | US5484711 DNA sequences, recombinant DNA molecules and processes for producing lipocortins III, IV, V & VI |
01/16/1996 | CA1337928C Topically applied gold organic complex |
01/11/1996 | WO1996000730A1 Vitronectin receptor antagonists |
01/11/1996 | WO1996000716A1 New salts of 2-[(2,6-dichlorophenyl)amine]phenylacetoxyacetic acid with organic basic cations |
01/11/1996 | WO1996000584A1 Anti-inflammatory wound healing compositions and methods for preparing and using same |
01/11/1996 | WO1996000581A1 Process to inhibit binding of the integrin alpha 4 beta 1 to vcam-1 or fibronectin |
01/11/1996 | WO1996000579A1 Aqueous cell extracts and aqueous suspensions of cell wall fractions from mycobacteria |
01/11/1996 | DE4422859A1 Wäßrige Zellextrakte und wäßrige Suspensionen von Zellwandfraktionen aus Mykobacterien Aqueous cell extracts and aqueous suspensions of cell wall fractions from mycobacteriae |
01/11/1996 | CA2194138A1 Aqueous cell extracts and aqueous suspensions of cell wall fractions from mycobacteria |
01/11/1996 | CA2193966A1 Vitronectin receptor antagonists |
01/11/1996 | CA2193828A1 Process to inhibit binding of the integrin alpha 4 beta 1 to vcam-1 or fibronectin |
01/11/1996 | CA2192682A1 New salts of 2-¬(2,6-dichlorophenyl)amine|phenylacetoxyacetic acid with organic basic cations |
01/11/1996 | CA2191604A1 Anti-inflammatory wound healing compositions and methods for preparing and using same |
01/10/1996 | EP0691401A1 Human manganese superoxide dismutase analogs, pharmaceutical compositions containing them, and use thereof |
01/10/1996 | EP0691350A2 uPA binding sites on domain 2+3 on uPAR and antibodies reactive therewith |
01/10/1996 | EP0691128A1 Methods of administering CRF antagonists |
01/10/1996 | EP0690872A1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
01/10/1996 | EP0690849A1 Heterocycle-containing amidine derivatives, their preparation and use |
01/10/1996 | EP0690841A1 Synthetic matrix metalloprotease inhibitors and uses thereof |
01/10/1996 | EP0690720A1 Therapeutic uses of bactericidal/permeability increasing protein products |
01/10/1996 | EP0690715A1 Topical and systemic application of buspirone or derivatives thereof for treatment of pathological conditions associated with immune responses |
01/10/1996 | EP0690673A1 Systemic gene treatment of connective tissue diseases |
01/10/1996 | EP0591255B1 Tetrahydrobenzazepine derivatives which inhibit lipoxygenase |
01/09/1996 | US5482966 Oxime derivatives |
01/09/1996 | US5482963 Pharmaceutical agents useful as leukotriene antagonists |
01/09/1996 | US5482934 Pregna-1,4-diene3,20-dione-16-17-acetal-21 esters, process for their preparation, composition, and methods for the treatment of inflammatory conditions |
01/09/1996 | US5482930 Anti-inflammatory composition and method with des-Tyr dynorphin and analogues |